BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines gAAP Diluted Earnings (Loss) per ADS ($/ADS, 1 ADS = 13 Ordinary Shares) ($)
Form 10-Q / 10-K Consolidated Statements of Operations & Form 8-K Non-GAAP Reconciliations
Latest, FY2025
2.53
Period ended Dec 31, 2025
Change on a year earlier
-141.3%
-6.12 in FY2024
History
7 years
Since FY2019
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | GAAP Diluted Earnings (Loss) per ADS ($/ADS, 1 ADS = 13 Ordinary Shares) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.53 | -141.3% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | -6.12 | -27.6% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | -8.45 | -56.5% | Form 10-K (filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | -19.43 | +23.7% | Form 10-K (filed 2025-02-27) ↗ |
| FY2021 | Dec 31, 2021 | -15.71 | -19.3% | Form 10-K (filed 2024-02-26) ↗ |
| FY2020 | Dec 31, 2020 | -19.47 | +23.2% | Form 10-K (filed 2023-02-27) ↗ |
| FY2019 | Dec 31, 2019 | -15.80 | – | Form 10-K (filed 2022-02-28) ↗ |
Breakdown
What makes up gaap diluted earnings (loss) per ads ($/ads, 1 ads = 13 ordinary shares)
- GAAP Basic Earnings (Loss) per ADS ($/ADS)2.63 · FY2025
- Non-GAAP Adjusted Diluted Earnings (Loss) per ADS ($/ADS)8.09 · FY2025
- Non-GAAP Adjusted Basic Earnings (Loss) per ADS ($/ADS)8.41 · FY2025
- Non-GAAP Adjusted Diluted Earnings (Loss) per Ordinary Share ($/sh)0.62 · FY2025
- Non-GAAP Adjusted Basic Earnings (Loss) per Ordinary Share ($/sh)0.65 · FY2025
- Weighted-Average Diluted ADSs Outstanding (M ADSs)113 · FY2025
- Weighted-Average Basic ADSs Outstanding (M ADSs)109 · FY2025
Cite this data
StockData. (2026). BeOne Medicines GAAP Diluted Earnings (Loss) per ADS ($/ADS, 1 ADS = 13 Ordinary Shares) ($), annual FY2019–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/eps_ads_diluted
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.